DIXON DONALD R sold $320K of AMPX (indirect holdings)

DIXON DONALD R sold 17,895 indirectly-held shares of Amprius Technologies, Inc. (AMPX) at $17.90 ($0.32M total) on 2026-05-26.

Original reporting
SEC EDGAR · DIXON DONALD R
Published May 28, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 8:40 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AMPX
Neutral
medium confidence
Mentioned
$AMPX
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AMPXNeutralLow
01

Why it matters

The newest fact is the director’s open-market sale details (shares, price, total value) and post-transaction holdings; it does not provide new company fundamentals.

02

Market read

Traders may briefly reassess sentiment around AMPX due to insider selling, but there is no accompanying fundamental catalyst in the text.

03

What to watch

The filing notes no pre-arranged 10b5-1 plan, which can increase interpretive noise; traders should watch for subsequent insider buys/sales and any concurrent company news.

Relevance 4/10Novelty 4/10Timing: filed 2026-05-28, transaction dated 2026-05-26

Background

The article is a SEC Form 4 insider transaction disclosure for Amprius Technologies, Inc. (AMPX).

Company-level read

Ticker impact

$AMPXNeutralMedium confidence
Context

Amprius Technologies disclosed a Form 4 showing director Dixon Donald R sold 17,895 shares in an open-market transaction for about $320K.

Expected impact

Likely limited near-term impact; any effect would be short-lived unless followed by additional disclosures or company-specific news.

Evidence & confidence

The filing is primary-source and time-stamped, but the transaction is modest in size and does not include new operational, financial, or regulatory information.

Market effects

No clear sector read-through from a single director sale without accompanying company guidance or regulatory developments.

None indicated.

None indicated.

Counterpoint

The sale could be for diversification, taxes, or pre-existing personal liquidity needs, so it may not reflect negative views on the business.

Key entities

  • Amprius Technologies, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • DIXON DONALD R

    Director who sold 17,895 shares of AMPX at $17.8962/share (indirect holdings).

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AMPXMedAI 8/10

Amprius (AMPX) Q3 2026 Earnings Call Transcript

Amprius reported Q3 2026 revenue of $39.1M, up 83% YoY, raising its full-year target to $145M. The company introduced SiCore 500 cells for aviation and secured a $75M U.S. defense contract. Amprius expanded into maritime vehicles and partnered with U.S. manufacturers for NDAA-compliant production.

$AMPXMedAI 8/10

Amprius Technologies Q3 Earnings Call Highlights

Amprius reported a Q3 net loss of $3.5M, with adjusted EBITDA at -$1M. The company maintained its full-year gross margin forecast of 28% and expects Q4 sales of $43.3M. Amprius is expanding manufacturing to meet demand, with a $75M contract for a U.S. battery production line. It also introduced new products for aviation and deep-sea applications, ending Q3 with $60.7M in cash.

$AMPXHigh

Amprius Technologies falls 7% on third quarter earnings miss

Amprius Technologies (NYSE:AMPX) reported Q3 earnings missing estimates with a loss of $0.02 per share, though revenue of $39.1M beat expectations. Shares fell 7.7% after-hours. The company raised its full-year 2026 revenue outlook to $145M, above analyst forecasts. Gross profit rose 217% YoY to $10.5M, with gross margin improving to 27%. Amprius secured a $75M U.S. Department of War contract and introduced a new battery cell.

$AMPXMed

Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent

Amprius Technologies, Inc. (AMPX) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Amprius Technologies Reports Third Quarter 2026 Financial Results and Recent Business Highlights • Q3 2026 revenue increased 83% year-over-year to $39.1 million • Net loss of $3.5 million, a 10% year-over-year improvement • Increasing 2026 revenue outlook to $145 mil

$AMPXHigh

AMPX Stock Jumps As Defense Deals Supercharge Growth Story

Amprius Technologies Inc. (NYSE: AMPX) shares rose 8.38% on October 21, 2026, driven by U.S. Department of War funding and a partnership with Caminus for battery production. The company secured $75M in funding for a high-energy-density cell plant, with revenue growth but negative margins. Canaccord Genuity initiated coverage with a Buy rating and $14 price target.